NCT02499952 Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors Status TERMINATED Phase PHASE2
NCT02494583 Study of Pembrolizumab (MK-3475) as First-Line Monotherapy and Combination Therapy for Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062) Status COMPLETED Phase PHASE3
NCT02493764 Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014) Status COMPLETED Phase PHASE3
NCT02492763 A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004) Status TERMINATED Phase PHASE2
NCT02492568 Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC Status COMPLETED Phase PHASE2
NCT02491788 Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers Status COMPLETED Phase PHASE4
NCT02484651 Can Adequacy of Anesthesia Depth and Quality of Recovery be Influenced by the Level of Neuromuscular Blockade? Status COMPLETED Phase PHASE4
NCT02484209 DiaFrail: A Short Duration Study in Older People ( DIAFRAIL Study) Status WITHDRAWN Phase PHASE3
NCT02478398 Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008) Status COMPLETED Phase PHASE3
NCT02477514 A Study to Evaluate the Effects of Tedizolid Phosphate on the Pharmacokinetics and Safety of Midazolam and Rosuvastatin (MK-1986-004) Status COMPLETED Phase PHASE1
NCT02475837 Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access Status COMPLETED Phase PHASE2
NCT02473692 Facilitating Migraine Medication Adherence and Optimizing Medication Use Status WITHDRAWN Phase N/A
NCT02473367 The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824) Status COMPLETED Phase PHASE1
NCT02466204 Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients Status COMPLETED Phase PHASE4
NCT02461563 A Multiple-Dose Study to Evaluate MK-1075 in Hepatitis C Virus (HCV) Infected Participants (MK-1075-004) Status COMPLETED Phase PHASE1
NCT02460198 Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164) Status COMPLETED Phase PHASE2
NCT02454179 Study of the Combination of Acalabrutinib (ACP-196) and Pembrolizumab in Advanced Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT02453594 Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087) Status COMPLETED Phase PHASE2
NCT02452424 A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors Status TERMINATED Phase PHASE1/PHASE2